Underutilization of Living Donor Liver Transplantation in the United States: Bias against MELD 20 and Higher
Ryan B. Perumpail, Eric R. Yoo, George Cholankeril, Lupe Hogan, Melodie Deis, Waldo C. Concepcion, C. Andrew Bonham, Zobair M. Younossi, Robert J. Wong, Aijaz Ahmed
[ Html ]
[ PDF ] 169-174
doi:10.14218/JCTH.2016.00029
HIV/HCV Antiviral Drug Interactions in the Era of Direct-acting Antivirals
Donald P. Rice, John J. Faragon, Sarah Banks, Lisa M. Chirch
[ Html ]
[ PDF ] 234-240
doi:10.14218/JCTH.2016.00026
Epidemiology of Hepatitis E in Pregnant Women and Children in Iran: A General Overview
Reza Taherkhani, Fatemeh Farshadpour
[ Html ]
[ PDF ] 269-276
doi:10.14218/JCTH.2016.00013
Pulmonary Manifestations among Patients with Primary Biliary Cirrhosis
Deniz Koksal, Aydin Seref Koksal, Ahmet Gurakar
[ Html ]
[ PDF ] 258-262
doi:10.14218/JCTH.2016.00024
Treatment of Hepatitis C in Patients Undergoing Immunosuppressive Drug Therapy
Kohtaro Ooka, Joseph K. Lim
[ Html ]
[ PDF ] 206-227
doi:10.14218/JCTH.2016.00017
Ursodeoxycholic Acid in Treatment of Non-cholestatic Liver Diseases: A Systematic Review
Jillian Reardon, Trana Hussaini, Majid Alsahafi, Vladimir Marquez Azalgara, Siegfried R. Erb, Nilufar Partovi, Eric M. Yoshida
[ Html ]
[ PDF ] 192-205
doi:10.14218/JCTH.2016.00023
Supplementing Conventional Treatment with Pycnogenol® May Improve Hepatitis C Virus–Associated Type 2 Diabetes: A Mini Review
Sayeh Ezzikouri, Fatima Zahra Jadid, Salsabil Hamdi, Lahcen Wakrim, Kyoko Tsukiyama-Kohara, Soumaya Benjelloun
[ Html ]
[ PDF ] 228-233
doi:10.14218/JCTH.2016.00021
PNPLA3 as a Genetic Determinant of Risk for and Severity of Non-alcoholic Fatty Liver Disease Spectrum
Habeeb Salameh, Muhannad Al Hanayneh, Maen Masadeh, Mohammed Naseemuddin, Tasnia Matin, Angelika Erwin, Ashwani K. Singal
[ Html ]
[ PDF ] 175-191
doi:10.14218/JCTH.2016.00009
Chronic Cholestatic Liver Injury Attributable to Vedolizumab
Jonathan G. Stine, Jennifer Wang, Brian W. Behm
[ Html ]
[ PDF ] 277-280
doi:10.14218/JCTH.2016.00018